75 related articles for article (PubMed ID: 15450247)
1. Cancer progression: is inhibin alpha from Venus or Mars?
Ball EM; Mellor SL; Risbridger GP
Cytokine Growth Factor Rev; 2004 Oct; 15(5):291-6. PubMed ID: 15450247
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluation of inhibin alpha subunit as a tumour suppressor in prostate cancer.
Risbridger GP; Ball EM; Wang H; Mellor SL; Peehl DM
Mol Cell Endocrinol; 2004 Oct; 225(1-2):73-6. PubMed ID: 15451570
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of inhibin alpha in prostate cancer.
Risbridger GP; Shibata A; Ferguson KL; Stamey TA; McNeal JE; Peehl DM
J Urol; 2004 Jan; 171(1):192-6. PubMed ID: 14665874
[TBL] [Abstract][Full Text] [Related]
4. GATA-4 is a granulosa cell factor employed in inhibin-alpha activation by the TGF-beta pathway.
Anttonen M; Parviainen H; Kyrönlahti A; Bielinska M; Wilson DB; Ritvos O; Heikinheimo M
J Mol Endocrinol; 2006 Jun; 36(3):557-68. PubMed ID: 16720723
[TBL] [Abstract][Full Text] [Related]
5. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice.
Matzuk MM; Finegold MJ; Su JG; Hsueh AJ; Bradley A
Nature; 1992 Nov; 360(6402):313-9. PubMed ID: 1448148
[TBL] [Abstract][Full Text] [Related]
6. Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
Hempel N; How T; Dong M; Murphy SK; Fields TA; Blobe GC
Cancer Res; 2007 Jun; 67(11):5231-8. PubMed ID: 17522389
[TBL] [Abstract][Full Text] [Related]
7. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
8. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
9. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
10. Loss of the expression and localization of inhibin alpha-subunit in high grade prostate cancer.
Mellor SL; Richards MG; Pedersen JS; Robertson DM; Risbridger GP
J Clin Endocrinol Metab; 1998 Mar; 83(3):969-75. PubMed ID: 9506758
[TBL] [Abstract][Full Text] [Related]
11. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate?
Sharifi N; Lechleider RJ; Farrar WL
J Mol Endocrinol; 2007 Nov; 39(5):329-32. PubMed ID: 17975259
[TBL] [Abstract][Full Text] [Related]
13. Inhibins: from reproductive hormones to tumor suppressors.
Stenvers KL; Findlay JK
Trends Endocrinol Metab; 2010 Mar; 21(3):174-80. PubMed ID: 20005735
[TBL] [Abstract][Full Text] [Related]
14. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
[TBL] [Abstract][Full Text] [Related]
15. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
16. [Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women].
Markova D; Milchev N; Batashki I; Uchikov A
Akush Ginekol (Sofiia); 2008; 47(1):16-9. PubMed ID: 18642569
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
18. An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis.
Kusumoto S; Kurashige M; Ohshima K; Tahara S; Matsui T; Nojima S; Hattori S; Morii E
Cancer Med; 2021 Mar; 10(5):1485-1500. PubMed ID: 33611864
[TBL] [Abstract][Full Text] [Related]
19. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
